Research output: Contribution to journal › Article › peer-review
15N NMR Hyperpolarization of Radiosensitizing Antibiotic Nimorazole by Reversible Parahydrogen Exchange in Microtesla Magnetic Fields. / Salnikov, Oleg G.; Chukanov, Nikita V.; Svyatova, Alexandra et al.
In: Angewandte Chemie - International Edition, Vol. 60, No. 5, 01.02.2021, p. 2406-2413.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - 15N NMR Hyperpolarization of Radiosensitizing Antibiotic Nimorazole by Reversible Parahydrogen Exchange in Microtesla Magnetic Fields
AU - Salnikov, Oleg G.
AU - Chukanov, Nikita V.
AU - Svyatova, Alexandra
AU - Trofimov, Ivan A.
AU - Kabir, Mohammad S.H.
AU - Gelovani, Juri G.
AU - Kovtunov, Kirill V.
AU - Koptyug, Igor V.
AU - Chekmenev, Eduard Y.
N1 - Funding Information: O.G.S. thanks the Russian Foundation for Basic Research (Grant 19‐33‐60045) for the support of mechanistic studies with the use of parahydrogen. E.Y.C. thanks the following awards for funding support: NSF CHE‐1904780 and NIH 1R21CA220137. N.V.C., A.S., K.V.K. and I.V.K. thank the Russian Foundation for Basic Research (grants 17‐54‐33037, 18‐33‐20019 and 19‐53‐12013) for financial support and the Russian Ministry of Science and Higher Education (Project AAAA‐A16‐116121510087‐5). Publisher Copyright: © 2020 Wiley-VCH GmbH Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/2/1
Y1 - 2021/2/1
N2 - Nimorazole belongs to the imidazole-based family of antibiotics to fight against anaerobic bacteria. Moreover, nimorazole is now in Phase 3 clinical trial in Europe for potential use as a hypoxia radiosensitizer for treatment of head and neck cancers. We envision the use of [15N3]nimorazole as a theragnostic hypoxia contrast agent that can be potentially deployed in the next-generation MRI-LINAC systems. Herein, we report the first steps to create long-lasting (for tens of minutes) hyperpolarized state on three 15N sites of [15N3]nimorazole with T1 of up to ca. 6 minutes. The nuclear spin polarization was boosted by ca. 67000-fold at 1.4 T (corresponding to P15N of 3.2 %) by 15N−15N spin-relayed SABRE-SHEATH hyperpolarization technique, relying on simultaneous exchange of [15N3]nimorazole and parahydrogen on polarization transfer Ir-IMes catalyst. The presented results pave the way to efficient spin-relayed SABRE-SHEATH hyperpolarization of a wide range of imidazole-based antibiotics and chemotherapeutics.
AB - Nimorazole belongs to the imidazole-based family of antibiotics to fight against anaerobic bacteria. Moreover, nimorazole is now in Phase 3 clinical trial in Europe for potential use as a hypoxia radiosensitizer for treatment of head and neck cancers. We envision the use of [15N3]nimorazole as a theragnostic hypoxia contrast agent that can be potentially deployed in the next-generation MRI-LINAC systems. Herein, we report the first steps to create long-lasting (for tens of minutes) hyperpolarized state on three 15N sites of [15N3]nimorazole with T1 of up to ca. 6 minutes. The nuclear spin polarization was boosted by ca. 67000-fold at 1.4 T (corresponding to P15N of 3.2 %) by 15N−15N spin-relayed SABRE-SHEATH hyperpolarization technique, relying on simultaneous exchange of [15N3]nimorazole and parahydrogen on polarization transfer Ir-IMes catalyst. The presented results pave the way to efficient spin-relayed SABRE-SHEATH hyperpolarization of a wide range of imidazole-based antibiotics and chemotherapeutics.
KW - hyperpolarization
KW - nimorazole
KW - parahydrogen
KW - radiosensitization
KW - SABRE-SHEATH
KW - PARA-HYDROGEN
KW - HEAD
KW - PRODRUG EVOFOSFAMIDE TH-302
KW - HYPOXIA
KW - NECK-CANCER
KW - SIGNAL AMPLIFICATION
KW - INDUCED POLARIZATION
KW - SABRE
KW - METRONIDAZOLE
KW - PET
UR - http://www.scopus.com/inward/record.url?scp=85097006619&partnerID=8YFLogxK
U2 - 10.1002/anie.202011698
DO - 10.1002/anie.202011698
M3 - Article
C2 - 33063407
AN - SCOPUS:85097006619
VL - 60
SP - 2406
EP - 2413
JO - Angewandte Chemie - International Edition
JF - Angewandte Chemie - International Edition
SN - 1433-7851
IS - 5
ER -
ID: 26204107